![]() | Up a level |
(2020) Potential drugs used in the antibody-drug conjugate (ADC) architecture for cancer therapy. Journal of Cellular Physiology. pp. 31-64. ISSN 0021-9541
(2020) Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy. Journal of Cellular Physiology. pp. 31-64. ISSN 00219541 (ISSN)
(2019) Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies. Clinical and Experimental Medicine. pp. 289-298. ISSN 1591-8890
(2019) Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology. pp. 5628-5642. ISSN 0021-9541
(2019) Antibody–drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes. Journal of Cellular Physiology. pp. 5628-5642. ISSN 00219541 (ISSN)